The reduced levels of SAM (on account of increased flux through COMT catalyzed reaction in the CRC–microbe model) can result in increased cancer cell proliferation and growth making COMT a promising drug target, an aspect that can motivate future experimental studies. This evidence concerns the gene COMT and cancer.